APPLICATION OF DIMETHYL BERBAMINE COMPOUND IN INHIBITION OF SARS-COV-2

A compound represented by the general Formula I, a geometric isomer thereof, or a pharmaceutically acceptable salt thereof, and/or a solvate thereof, and/or a hydrate thereof for preventing and/or treating a pulmonary disease or symptom associated with SARS-CoV-2 or an asymptomatic or symptomatic SARS-CoV-2 infection, and an application of the compound represented by the general Formula I, the geometric isomer thereof, or the pharmaceutically acceptable salt thereof, and/or the solvate thereof, and/or the hydrate thereof in preparation of a product for preventing and/or treating a pulmonary disease or symptom associated with SARS-CoV-2 or asymptomatic or symptomatic SARS-CoV-2 infection,.

Medienart:

Patent

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Europäisches Patentamt - (2024) vom: 27. März Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

ZHONG WU [VerfasserIn]
QIN CHENGFENG [VerfasserIn]
ZHOU XINBO [VerfasserIn]
DENG YONGQIANG [VerfasserIn]
HU JIQIANG [VerfasserIn]
JIN QINGPING [VerfasserIn]
YU BIN [VerfasserIn]
CAO RUIYUAN [VerfasserIn]
WANG MANLI [VerfasserIn]
LI XIAOFENG [VerfasserIn]
ZHANG NANA [VerfasserIn]
FAN SHIYONG [VerfasserIn]
HU ZHIHONG [VerfasserIn]
LI SONG [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C07D: Heterocyclic compounds (macromolecular compounds c0 (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2024-03-27, Last update posted on www.tib.eu: 2024-04-09, Last updated: 2024-04-15

Patentnummer:

EP4124337

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA000325147